Basecamp Research, the London-headquartered firm applying frontier AI to therapeutic design, has landed $140.0M in Series C funding. The round drew investment from S32 and True.
The company's EDEN models are trained on BaseData, a proprietary evolutionary genomic dataset that boasts over 100 billion novel genes, sourced through partnerships spanning more than 30 countries and all seven continents. Basecamp Research is now pushing a pipeline of EDEN-designed therapeutics toward clinical development from its London and Boston locations.


















